CC-UC-00302 - Immunization at Pharmacy

Actors

  • Client (child 5+, adult 18+)
  • Parent/guardian/client caregiver
  • Pharmacy technician (PT)
  • Pharmacist

Pre-conditions

  • Client is following provincial/territorial immunization schedule for COVID-19 (child 12+) and/or influenza (child 5+).
  • Client meets the eligibility criteria to receive an immunization in a pharmacy setting.
  • Client is covered under provincial/territorial health care insurance.
Step Description Data elements collected Result
1 Pharmacy technician (PT) uses health card to verify client's demographic information.
  • Person Identifier Type
  • Person Identifier Value
  • Person Identifier Assigner
  • Person Given Name
  • Person Middle Name (if applicable)
  • Person Surname
  • Date of Birth
  • Recorded Sex or Gender (if verified)
Client demographic information is validated and recorded in the client's medical record.
2 PT verifies client's allergy(ies) status.
  • Allergy or Intolerance Clinical Status
Allery status is verified and details are recorded in the medical record. CC-UC-00305 Client is allergic to immunization compound.
3 PT verifies client's temperature.
  • Date and Time of Observation
  • Measurement Type
  • Unit of Measure
  • Body Temperature
  • Body Temperature Measurement Method
Client temperature is taken and details recorded it the client's medical record. CC-UC-00306 Client has fever
4 Pharmacist provides immunization education and obtains consent from client.
  • Document Date and Time
  • Document Status
  • Document Principal Author
  • Document Type
  • Document Recipient
  • Document Content
Immunization education is provided and consent is obtained and recorded in the client's medical record. CC-UC-00307 Consent not given to immunize.
5 Pharmacist administers immunization(s) to client.
  • Immunization Reporting Source
  • Immunization
  • Immunization Expiration Date
  • Immunization Market Authorization Holder
  • Immunization Lot Number
  • Immunization Series Doses
  • Immunization Dose Number
  • Immunization Reason
  • Immunization Dose Volume
  • Immunization Dose Unit of Measure
  • Immunization Route of Administration
  • Immunization Site
  • Immunization Date
  • Immunization Status
  • Immunization Performer Role
Immunization is administered and recorded in the client's medical record.
6 Pharmacist instructs client to remain at clinic for post-immunization monitoring as per local policy.
  • Post-Procedure Instructions
  • Date and Time of Observation (if the beginning of the observation period is documented)
  • Immunization Reaction (only if a reaction occurs)
  • Immunization Reaction Date and Time (if applicable)
  • Immunization Reaction Reporter (if applicable)
Client remains at the pharmacy for post-immunization monitoring.
7 The Pharmacist provides the client with an updated immunization record.
  • Document Date and Time
  • Document Status
  • Document Principal Author
  • Document Type
  • Document Recipient
  • Document Content
An updated immunization record is provided and recorded in the client's medical record.
8 Client leaves the pharmacy after the appropriate monitoring period.
  • Date and Time of Observation (if completion of the monitoring period is documented)
  • Immunization Reaction (only if a reaction occurred)
  • Immunization Reaction Date and Time (if applicable)
The client leaves the pharmacy. CC-UC-00308 Immunization incident.
9 This use case ends. Not applicable Not applicable

Post-conditions

  • Client demographic information is validated.
  • Allery status is verified.
  • Immunization education is provided and consent is obtained.
  • Immunization is administered.
  • An updated immunization record is provided.
  • Client's medical record is updated.

Contact us

If you have questions about this initiative, would like to be added to our stakeholder notification list or would like to participate in our consultations, please email us.

connectedcare@cihi.ca

How to cite:

Canadian Institute for Health Information. CC-UC-00302 - Immunization at Pharmacy. Accessed November 02, 2026.